Foghorn Therapeutics Inc.
FHTX
|
$5.78
-4.15%
-4.69%
140K
|
Health Technology
(0.0% 1d) (-4.8% 1m) (-18.9% 1y) (0.0% 2d) (-4.1% 3d) (-22.1% 7d) (56.15% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 246,030,925
http://www.foghorntx.com
Sec Filling | Patents | 85 employees
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.
glass msa
add to watch list Paper trade email alert is off
Press-releases
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
FHTX | $5.78 -4.15% -4.69% 140K
|
Health Technology
|
| O: -14.72%
H: 0.08%
C: -2.74%
therapeutics financial
Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs
Published: 2024-04-09 (Crawled : 21:00) - globenewswire.com
FHTX | $5.78 -4.15% -4.69% 140K
|
Health Technology
|
| O: -4.01%
H: 9.92%
C: 1.11%
fhd-909 ep300 preclinical therapeutics potential
Foghorn Therapeutics to Participate in Needham’s 23rd Annual Virtual Healthcare Conference
Published: 2024-04-05 (Crawled : 11:00) - globenewswire.com
FHTX | $5.78 -4.15% -4.69% 140K
|
Health Technology
|
| O: 0.58%
H: 3.86%
C: 1.57%
conference therapeutics
Foghorn to Host Conference Call and Webcast on Pipeline of Potential First-in-Class Medicines in Conjunction with the 2024 AACR Annual Meeting
Published: 2024-03-26 (Crawled : 11:00) - globenewswire.com
FHTX | $5.78 -4.15% -4.69% 140K
|
Health Technology
|
| O: 2.19%
H: 2.39%
C: 0.0%
conference pipeline meeting potential
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Published: 2024-03-19 (Crawled : 12:30) - prnewswire.com
OMGA | $2.555 6.02% 6.04% 350K
|
|
| O: 0.0%
H: 1.42%
C: -2.56%
SANA | $8.26 -1.78% -1.75% 1.4M
|
|
| O: -1.57%
H: 1.48%
C: -1.37%
MCRB | $0.6273 -1.38% -1.39% 3K
|
Health Technology
|
| O: 0.22%
H: 12.36%
C: 6.11%
MRNA | News S | $103.44 -0.34% -0.33% 570
|
Health Technology
|
| O: -0.35%
H: 1.59%
C: 1.16%
FHTX | $5.78 -4.15% -4.69% 140K
|
Health Technology
|
| O: -1.01%
H: 5.45%
C: 3.41%
DNLI | $16.82 -3.0% -3.15% 960K
|
Health Technology
|
| O: -0.75%
H: 3.41%
C: 3.01%
companies
Foghorn Therapeutics Provides Financial Update for 2023 and 2024 Strategic Outlook
Published: 2024-03-07 (Crawled : 12:00) - globenewswire.com
FHTX | $5.78 -4.15% -4.69% 140K
|
Health Technology
|
| O: 1.03%
H: 3.94%
C: -0.44%
update therapeutics financial
Foghorn Therapeutics to Present New Preclinical Data at 2024 AACR Annual Meeting, Reflecting Advances with Multiple Potential First-in-Class Medicines, including the Selective Inhibitor of BRM, FHD-909
Published: 2024-03-05 (Crawled : 22:00) - globenewswire.com
FHTX | $5.78 -4.15% -4.69% 140K
|
Health Technology
|
| O: 0.0%
H: 11.74%
C: 6.26%
fhd-909 preclinical therapeutics potential
Foghorn Therapeutics to Participate in Cowen’s 44th Annual Health Care Conference
Published: 2024-02-28 (Crawled : 12:00) - globenewswire.com
FHTX | $5.78 -4.15% -4.69% 140K
|
Health Technology
|
| O: -0.42%
H: 9.97%
C: 8.51%
conference health care therapeutics
Foghorn Provides Pipeline Update on FHD-909 BRM Selective Inhibitor
Published: 2024-02-08 (Crawled : 12:00) - globenewswire.com
FHTX | $5.78 -4.15% -4.69% 140K
|
Health Technology
|
| O: 14.42%
H: 62.18%
C: 35.85%
fhd-909 update pipeline
Foghorn Therapeutics Highlights Clinical Program Updates and Research Progress and Provides Strategic Objectives for 2024
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
FHTX | $5.78 -4.15% -4.69% 140K
|
Health Technology
|
| O: 0.35%
H: 6.89%
C: 6.01%
research program therapeutics
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 49.67% 1.4M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
HOLO | $2.24 -5.49% 27.74% 7.7M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VIAO | $0.262 0.77% 16.03% 14M
|
Electronic Technology
DXF | $0.2708 -5.71% 14.48% 190K
|
Finance
GRFX | $0.2159 -10.04% 12.55% 5.9K
|
n/a
BHIL | $0.1722 -3.8% 12.08% 290K
|
Agriculture, Forestry, Fishing ...
MCW 4 | $6.49 -1.22% 10.94% 6
|
Professional, Scientific, and T...
Last 48 Hours Insiders Buying
IZEA | $2.53 1.2% -2.4% 0
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.58% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.37 -1.41% -1.02% 0
|
Retail Trade
|
22:00
BRN P 10650 | $2.79 2.2% 0.0% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 0
|
Health Technology
|
16:30
RMCF | $3.53 -3.16% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10